Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort

Authors

Institutions

Publication Details

Journal
Journal of Hematology & Oncology
Published
2025-11-14
DOI
https://doi.org/10.1186/s13045-025-01751-w
Citations
6
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
10.62
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort

Pau Montesinos, Andrew H. Wei, Justin M. Watts, Pierre Fenaux et al.
6 citations
Journal of Hematology & Oncology
Acute Myeloid Leukemia Research
10.62
article

Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort

Pau Montesinos, Andrew H. Wei, Justin M. Watts, Pierre Fenaux, Stéphane de Botton, Hua Tian, Aaron Sheppard, Eunice S. Wang, David Taussig, Christophe Marzac, Karen W L Yee, Brian A. Jonas, Antonio Curti, Christian Récher, Jorge Alberto Cortés, Jürgen Krauter
article en
6 citations

Abstract

No abstract available for this paper.
Journal of Hematology & OncologyVol. 18(1)
Roswell Park Comprehensive Cancer Center (US), The Royal Melbourne Hospital (AU), University of Miami (US), Inserm (FR), Walter and Eliza Hall Institute of Medical Research (AU), Université Paris Cité (FR), Augusta University (US), Université Paris-Saclay (FR), Peter MacCallum Cancer Centre (AU), Institut Gustave Roussy (FR), Princess Margaret Cancer Centre (CA), Hospital Universitari i Politècnic La Fe (ES), Centre Hospitalier Universitaire de Toulouse (FR), Augusta University Health (US), Institut universitaire du cancer de Toulouse Oncopole (FR), Klinikum Braunschweig (DE), Azienda USL di Bologna (IT), Royal Marsden Hospital (GB), National Cancer Center of Georgia (GE), Hôpital Saint-Louis (FR), Sylvester Comprehensive Cancer Center (US), Rigel (United States) (US), Sunesis (United States) (US), University of California, Davis (US)
Openalex Percentile: Top 2%
Acute Myeloid Leukemia Research
10.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.